Growing Bioengineering to Attend Health Food Conferences in Tokyo and Madrid

SHANGHAI, Sept. 22 /PRNewswire-Asia-FirstCall/ -- China-Biotics, Inc. (Nasdaq: CHBT) ("China-Biotics" or "the Company"), the leading developer, manufacturer and distributor of probiotics products in China, today announced that its wholly-owned subsidiary Growing Bioengineering Company Limited, will attend health food conferences in Tokyo and Madrid later in 2010.

Growing Bioengineering will present at the Health Ingredients Japan 2010 conference in Tokyo, Japan. The annual exhibition is hosted by UBM Media Co., Ltd. and has been ongoing since 1989. An estimated 400 presenting companies will attend this year's event from Wednesday, October 13th to Friday, October 15th at the Tokyo Big Sight Exhibition Center in Tokyo, Japan.

Growing Bioengineering will also present at the 2010 Health Ingredients Europe conference in Madrid, Spain. The bi-annual exhibition is hosted by CMP Information. An estimated 140 exhibitors and over 9,000 visitors will present on subjects such as biotechnology, dietary supplements, food manufacturing, etc., from November 16th to November 18th at Ifema - Parque Ferial Juan Carlos in Madrid, Spain.

Mr. Jinan Song, Chairman and CEO of China-Biotics, commented, "The global probiotics market is expected to maintain robust growth in the future. We look forward to participating in more global industry events to help us stay abreast of the latest industry dynamics, market intelligence and help promote our brand to a global audience. We have established our international sales team to pursue global market opportunities, as we are confident in our product quality and pricing competitiveness. Our long-term corporate strategic direction remains to focus on growing our business in China and eventually diversifying our revenue source to overseas market."

About China-Biotics

China-Biotics, Inc. ("China-Biotics" or "the Company"), a leading manufacturer of biotechnology products and supplements, engages in the research, development, marketing and distribution of probiotics dietary supplements in China. Through its wholly owned subsidiaries, Shanghai Shining Biotechnology Co., Ltd. and Growing Bioengineering (Shanghai) Co. Ltd., the Company develops and produces its proprietary product portfolio. Currently, the retail products are sold OTC mainly through large distributors to pharmacies and supermarkets in Shanghai, Jiangsu, and Zhejiang province. The Company also sells bulk products to institutional customers such as dairy and animal feed producers, as well as pharmaceutical companies. In February 2010, China-Biotics began its commercial production in China's largest probiotics production facility to meet growing demand in China. For more information, please visit http://www.chn-biotics.com .

    For more information, please contact:

    China-Biotics, Inc.
     Travis Cai
     Chief Financial Officer
     Email: [email protected]

    Grayling
     Kevin Theiss / Shiwei Yin
     Tel:   +1-646-284-9409
     Email: [email protected]
            [email protected]

SOURCE China-Biotics, Inc.